AAAAAA
Results:
1-12
|
Results: 12
Authors:
BROOKS DP
ADAMS J
DEPALMA PD
WEBB EF
GRISWOLD DE
PALMER R
Citation: Dp. Brooks et al., THE SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR, CELECOXIB, BUT NOT 6MNA, AFFECTS RENAL HEMODYNAMIC AND RENAL-FUNCTION IN THE DOG, Journal of investigative medicine, 46(3), 1998, pp. 227-227
Authors:
GRISWOLD DE
WEBB EF
BADGER AM
GORYCKI PD
LEVANDOSKI PA
BARNETTE MA
GROUS M
CHRISTENSEN S
TORPHY TJ
Citation: De. Griswold et al., SE-207499 (ARIFLO), A 2ND-GENERATION PHOSPHODIESTERASE-4 INHIBITOR, REDUCES TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-4 PRODUCTION IN-VIVO, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 705-711
Authors:
WEBB EF
TZIMAS MN
NEWSHOLME SJ
GRISWOLD DE
Citation: Ef. Webb et al., INTRALESIONAL CYTOKINES IN CHRONIC OXAZOLONE-INDUCED CONTACT SENSITIVITY SUGGEST ROLES FOR TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-4, Journal of investigative dermatology, 111(1), 1998, pp. 86-92
Authors:
GRISWOLD DE
WEBB EF
Citation: De. Griswold et Ef. Webb, CUTANEOUS CYTOKINE PRODUCTION FROM INITIAL OXAZOLONE EXPOSURE, Journal of investigative dermatology, 110(4), 1998, pp. 663-663
Authors:
SARAU HM
GRISWOLD DE
POTTS W
FOLEY JJ
SCHMIDT DB
WEBB EF
MARTIN LD
BRAWNER ME
ELSHOURBAGY NA
MEDHURST AD
GIARDINA GAM
HAY DWP
Citation: Hm. Sarau et al., NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS .1. PHARMACOLOGICAL AND PHARMACOKINETIC CHARACTERIZATION OF SB-223412, A NOVEL, POTENT AND SELECTIVE NEUROKININ-3 RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1303-1311
Authors:
ADAMS JL
GARIGIPATI RS
SORENSON M
SCHMIDT SJ
BRIAN WR
NEWTON JF
TYRRELL KA
GARVER E
YODIS LA
CHABOTFLETCHER M
TZIMAS M
WEBB EF
BRETON JJ
GRISWOLD DE
Citation: Jl. Adams et al., BICYCLIC N-HYDROXYUREA INHIBITORS OF 5-LIPOXYGENASE - PHARMACODYNAMIC, PHARMACOKINETIC, AND IN-VITRO METABOLIC STUDIES CHARACTERIZING (2,3-DIHYDRO-6-(PHENYLMETHOXY)-3-BENZOFURANYL)UREA, Journal of medicinal chemistry, 39(26), 1996, pp. 5035-5046
Authors:
GRISWOLD DE
CHABOTFLETCHER M
WEBB EF
MARTIN L
HILLEGASS L
Citation: De. Griswold et al., ANTIINFLAMMATORY ACTIVITY OF TOPICAL AURANOFIN IN ARACHIDONIC ACID-INDUCED AND PHORBOL ESTER-INDUCED INFLAMMATION IN MICE, Drug development research, 34(4), 1995, pp. 369-375
Authors:
REDDY MP
WEBB EF
CASSATT D
MALEY D
LEE JC
GRISWOLD DE
TRUNEH A
Citation: Mp. Reddy et al., PYRIDINYL IMIDAZOLES INHIBIT THE INFLAMMATORY PHASE OF DELAYED-TYPE HYPERSENSITIVITY REACTIONS WITHOUT AFFECTING T-DEPENDENT IMMUNE-RESPONSES, International journal of immunopharmacology, 16(10), 1994, pp. 795-804
Authors:
MARSHALL LA
WINKLER JD
GRISWOLD DE
BOLOGNESE B
ROSHAK A
SUNG CM
WEBB EF
JACOBS R
Citation: La. Marshall et al., EFFECTS OF SCALARADIAL, A TYPE-II PHOSPHOLIPASE A(2) INHIBITOR, ON HUMAN NEUTROPHIL ARACHIDONIC-ACID MOBILIZATION AND LIPID MEDIATOR FORMATION, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 709-717
Authors:
MURTHY SN
MURTHY N
GRISWOLD DE
HILLEGAS LM
WEBB EF
Citation: Sn. Murthy et al., INHIBITION OF LEUKOTRIENE BIOSYNTHESIS, CYTOKINE PRODUCTION AND DISEASE SEVERITY IN DEXTRAN SULFATE-MEDIATED COLITIS IN THE MOUSE BY SK-AND-F 107649, A SELECTIVE 5-LIPOXYGENASE (5-LO) INHIBITOR, Gastroenterology, 106(4), 1994, pp. 10000741-10000741
Authors:
GRISWOLD DE
WEBB EF
BRETON J
WHITE JR
MARSHALL PJ
TORPHY TJ
Citation: De. Griswold et al., EFFECT OF SELECTIVE PHOSPHODIESTERASE TYPE-IV INHIBITOR, ROLIPRAM, ONFLUID AND CELLULAR-PHASES OF INFLAMMATORY RESPONSE, Inflammation, 17(3), 1993, pp. 333-344
Authors:
BADGER AM
SWIFT BA
WEBB EF
CLARK RK
BUGELSKI PJ
GRISWOLD DE
Citation: Am. Badger et al., BENEFICIAL-EFFECTS OF SK-AND-F-105685 IN RAT ADJUVANT ARTHRITIS - PROPHYLACTIC AND THERAPEUTIC EFFECTS ON DISEASE PARAMETER PROGRESSION, International journal of immunopharmacology, 15(3), 1993, pp. 343
Risultati:
1-12
|